Lipoproteins transfer lipids (fats) around the body in the extracellular fluid, making fats available to body cells for receptor-mediated endocytosis.[2][3] Lipoproteins are complex particles composed of multiple proteins, typically 80–100 proteins per particle (organized by a single apolipoprotein B for LDL and the larger particles). A single LDL particle is about 220–275 angstroms in diameter, typically transporting 3,000 to 6,000 fat molecules per particle, and varying in size according to the number and mix of fat molecules contained within.[4] The lipids carried include all fat molecules with cholesterol, phospholipids, and triglycerides dominant; amounts of each vary considerably.[5]
A good clinical interpretation of blood lipid levels is that high LDL, in combination with a high amount of triglycerides, which indicates a high likelihood of the LDL being oxidised, is associated with increased risk of cardiovascular diseases.[6]
Biochemistry
Structure
Each native LDL particle enables emulsification, i.e. surrounding the fatty acids being carried, enabling these fats to move around the body within the water outside cells. Each particle contains a single apolipoprotein B-100 molecule (Apo B-100, a protein that has 4536 amino acid residues and a mass of 514 kDa), along with 80 to 100 additional ancillary proteins. Each LDL has a highly hydrophobic core consisting of polyunsaturated fatty acid known as linoleate and hundreds to thousands (about 1500 commonly cited as an average) of esterified and unesterified cholesterol molecules. This core also carries varying numbers of triglycerides and other fats and is surrounded by a shell of phospholipids and unesterified cholesterol, as well as the single copy of Apo B-100. LDL particles are approximately 22 nm (0.00000087 in.) to 27.5 nm in diameter and have a mass of about 3 million daltons.[7] Since LDL particles contain a variable and changing number of fatty acid molecules, there is a distribution of LDL particle mass and size.[4] Determining the structure of LDL has been difficult for biochemists because of its heterogeneous structure. However, the structure of LDL at human body temperature in native condition, with a resolution of about 16 Angstroms using cryogenic electron microscopy, has been described in 2011.[8]
Physiology
LDL particles are formed when triglycerides are removed from VLDL by the lipoprotein lipase enzyme (LPL) and they become smaller and denser (i.e. fewer fat molecules with same protein transport shell), containing a higher proportion of cholesterol esters.[9][10]
Transport into the cell
When a cell requires additional cholesterol (beyond its current internal HMGCoA production pathway), it synthesizes the necessary LDL receptors as well as PCSK9, a proprotein convertase that marks the LDL receptor for degradation.[11] LDL receptors are inserted into the plasma membrane and diffuse freely until they associate with clathrin-coated pits. When LDL receptors bind LDL particles in the bloodstream, the clathrin-coated pits are endocytosed into the cell.[citation needed]
Vesicles containing LDL receptors bound to LDL are delivered to the endosome. In the presence of low pH, such as that found in the endosome, LDL receptors undergo a conformation change, releasing LDL. LDL is then shipped to the lysosome, where cholesterol esters in the LDL are hydrolysed. LDL receptors are typically returned to the plasma membrane, where they repeat this cycle. If LDL receptors bind to PCSK9, however, transport of LDL receptors is redirected to the lysosome, where they are degraded.[12]
Role in the innate immune system
LDL interferes with the quorum sensing system that upregulates genes required for invasive Staphylococcus aureus infection. The mechanism of antagonism entails binding apolipoprotein B to a S. aureusautoinducer pheromone, preventing signaling through its receptor. Mice deficient in apolipoprotein B are more susceptible to invasive bacterial infection.[13]
LDL size patterns
LDL can be grouped based on its size: large low density LDL particles are described as pattern A, and small high density LDL particles are pattern B.[14]Pattern B has been associated by some with a higher risk for coronary heart disease.[15]: 1–10 This is thought to be because the smaller particles are more easily able to penetrate the endothelium of arterial walls. Pattern I, for intermediate, indicates that most LDL particles are very close in size to the normal gaps in the endothelium (26 nm). According to one study, sizes 19.0–20.5 nm were designated as pattern B and LDL sizes 20.6–22 nm were designated as pattern A.[16] Other studies have shown no such correlation at all.[17]
Some evidence suggests the correlation between Pattern B and coronary heart disease is stronger than the correspondence between the LDL number measured in the standard lipid profile test. Tests to measure these LDL subtype patterns have been more expensive and not widely available, so the common lipid profile test is used more often.[15]
There has also been noted a correspondence between higher triglyceride levels and higher levels of smaller, denser LDL particles and alternately lower triglyceride levels and higher levels of the larger, less dense ("buoyant") LDL.[18][19]
With continued research, decreasing cost, greater availability and wider acceptance of other lipoprotein subclass analysis assay methods, including NMR spectroscopy, research studies have continued to show a stronger correlation between human clinically obvious cardiovascular events and quantitatively measured particle concentrations.[20]
Oxidized LDL
Oxidized LDL is a general term for LDL particles with oxidatively modified structural components. As a result, from free radical attack, both lipid and protein parts of LDL can be oxidized in the vascular wall. Besides the oxidative reactions taking place in vascular wall, oxidized lipids in LDL can also be derived from oxidized dietary lipids.[21][22] Oxidized LDL is known to associate with the development of atherosclerosis, and it is therefore widely studied as a potential risk factor of cardiovascular diseases.[23] Atherogenicity of oxidized LDL has been explained by lack of recognition of oxidation-modified LDL structures by the LDL receptors, preventing the normal metabolism of LDL particles and leading eventually to development of atherosclerotic plaques.[23] Of the lipid material contained in LDL, various lipid oxidation products are known as the ultimate atherogenic species.[24] Acting as a transporter of these injurious molecules is another mechanism by which LDL can increase the risk of atherosclerosis.[22][25]
Testing
Blood tests commonly report LDL-C: the amount of cholesterol which is estimated to be contained with LDL particles, on average, using a formula, the Friedewald equation. In clinical context, mathematically calculated estimates of LDL-C are commonly used as an estimate of how much low density lipoproteins are driving progression of atherosclerosis. The problem with this approach is that LDL-C values are commonly discordant with both direct measurements of LDL particles and actual rates of atherosclerosis progression.[citation needed]
Direct LDL measurements are also available and better reveal individual issues but are less often promoted or done due to slightly higher costs and being available from only a couple of laboratories in the United States. In 2008, the ADA and ACC recognized direct LDL particle measurement by NMR as superior for assessing individual risk of cardiovascular events.[26]
Estimation of LDL particles via cholesterol content
Chemical measures of lipid concentration have long been the most-used clinical measurement, not because they have the best correlation with individual outcome, but because these lab methods are less expensive and more widely available.
The lipid profile does not measure LDL particles. It only estimates them using the Friedewald equation[19][27]
by subtracting the amount of cholesterol associated with other particles, such as HDL and VLDL, assuming a prolonged fasting state, etc.:
where H is HDL cholesterol, L is LDL cholesterol, C is total cholesterol, T are triglycerides, and k is 0.20 if the quantities are measured in mg/dL and 0.45 if in mmol/L.
There are limitations to this method, most notably that samples must be obtained after a 12 to 14 h fast and that LDL-C cannot be calculated if plasma triglyceride is >4.52 mmol/L (400 mg/dL). Even at triglyceride levels 2.5 to 4.5 mmol/L, this formula is considered inaccurate.[28] If both total cholesterol and triglyceride levels are elevated then a modified formula, with quantities in mg/dL, may be used
This formula provides an approximation with fair accuracy for most people, assuming the blood was drawn after fasting for about 14 hours or longer, but does not reveal the actual LDL particle concentration because the percentage of fat molecules within the LDL particles which are cholesterol varies, as much as 8:1 variation. There are several formulas published addressing the inaccuracy in LDL-C estimation.[29][30][31] The inaccuracy is based on the assumption that VLDL-C (Very low density lipoprotein cholesterol) is always one-fifth of the triglyceride concentration. Another formulae addresses this issue by using an adjustable factor [32] or by using a regression equation.[33] There are few studies which have compared the LDL-C values derived from this formula and values obtained by direct enzymatic method.[34] Direct enzymatic method are found to be accurate and it has to be the test of choice in clinical situations. In the resource poor settings, the option of using the formula has to be considered.[34]
However, the concentration of LDL particles, and to a lesser extent their size, has a stronger and consistent correlation with individual clinical outcome than the amount of cholesterol within LDL particles, even if the LDL-C estimation is approximately correct. There is increasing evidence and recognition of the value of more targeted and accurate measurements of LDL particles. Specifically, LDL particle number (concentration), and to a lesser extent size, have shown slightly stronger correlations with atherosclerotic progression and cardiovascular events than obtained using chemical measures of the amount of cholesterol carried by the LDL particles.[35] It is possible that the LDL cholesterol concentration can be low, yet LDL particle number high and cardiovascular events rates are high. Correspondingly, it is possible that LDL cholesterol concentration can be relatively high, yet LDL particle number low and cardiovascular events are also low.[citation needed]
Normal ranges
In the US, the American Heart Association, NIH, and NCEP provide a set of guidelines for fasting LDL-Cholesterol levels, estimated or measured, and risk for heart disease. As of about 2005, these guidelines were:[36][37][38]
Optimal LDL cholesterol, levels in healthy young children before onset of atherosclerotic plaque in heart artery walls
<70
<1.8
Optimal LDL cholesterol, corresponding to lower rates of progression, promoted as a target option for those known to clearly have advanced symptomatic cardiovascular disease
<100
<2.6
Optimal LDL cholesterol, corresponding to lower, but not zero, rates for symptomatic cardiovascular disease events
100 to 129
2.6 to 3.3
Near optimal LDL level, corresponding to higher rates for developing symptomatic cardiovascular disease events
130 to 159
3.3 to 4.1
Borderline high LDL level, corresponding to even higher rates for developing symptomatic cardiovascular disease events
160 to 199
4.1 to 4.9
High LDL level, corresponding to much higher rates for developing symptomatic cardiovascular disease events
>200
>4.9
Very high LDL level, corresponding to highest increased rates of symptomatic cardiovascular disease events
Over time, with more clinical research, these recommended levels keep being reduced because LDL reduction, including to abnormally low levels, was the most effective strategy for reducing cardiovascular death rates in one large double blind, randomized clinical trial of men with hypercholesterolemia;[39] far more effective than coronary angioplasty/stenting or bypass surgery.[40]
For instance, for people with known atherosclerosis diseases, the 2004 updated American Heart Association, NIH and NCEP recommendations are for LDL levels to be lowered to less than 70 mg/dL. This low level of less than 70 mg/dL was recommended for primary prevention of 'very-high risk patients' and in secondary prevention as a 'reasonable further reduction'. This position was disputed.[41] Statin drugs involved in such clinical trials have numerous physiological effects beyond simply the reduction of LDL levels.
From longitudinal population studies following progression of atherosclerosis-related behaviors from early childhood into adulthood,[42] the usual LDL in childhood, before the development of fatty streaks, is about 35 mg/dL. However, all the above values refer to chemical measures of lipid/cholesterol concentration within LDL, not measured low-density lipoprotein concentrations, the accurate approach.[35]
A study was conducted measuring the effects of guideline changes on LDL cholesterol reporting and control for diabetes visits in the US from 1995 to 2004. It was found that although LDL cholesterol reporting and control for diabetes and coronary heart disease visits improved continuously between 1995 and 2004,[43][44] neither the 1998 ADA guidelines nor the 2001 ATP III guidelines increased LDL cholesterol control for diabetes relative to coronary heart disease.[45]
Direct measurement of LDL particle concentrations
There are several competing methods for measurement of lipoprotein particle concentrations and size. The evidence is that the NMR methodology (developed, automated & greatly reduced in costs while improving accuracy as pioneered by Jim Otvos and associates) results in a 22-25% reduction in cardiovascular events within one year,[46] contrary to the longstanding claims by many in the medical industry that the superiority over existing methods was weak, even by statements of some proponents.[47]
Since the later 1990s, because of the development of NMR measurements, it has been possible to clinically measure lipoprotein particles at lower cost [under $80 US (including shipping) & is decreasing; versus the previous costs of >$400 to >$5,000] and higher accuracy. There are two other assays for LDL particles, however, like LDL-C, most only estimate LDL particle concentrations.[citation needed]
Direct LDL particle measurement by NMR was mentioned by the ADA and ACC, in a 28 March 2008 joint consensus statement,[48] as having advantages for predicting individual risk of atherosclerosis disease events, but the statement noted that the test is less widely available, is more expensive [about $13.00 US (2015 without insurance coverage) from some labs which use the Vantera Analyzer[49]]. Debate continues that it is "...unclear whether LDL particle size measurements add value to measurement of LDL-particle concentration", though outcomes have always tracked LDL particle, not LDL-C, concentrations.
Using NMR, the total LDL particle concentrations, in nmol/L plasma, are typically subdivided by percentiles referenced to the 5,382 men and women, not on any lipid medications, who are participating in the MESA trial.[50]
LDL particle concentration can also be measured by measuring the concentration of the protein ApoB, based on the generally accepted principle that each LDL or VLDL particle carries one ApoB molecule.[51]
Optimal ranges
The LDL particle concentrations are typically categorized by percentiles, <20%, 20–50%, 50th–80th%, 80th–95% and >95% groups of the people participating and being tracked in the MESA trial, a medical research study sponsored by the United States National Heart, Lung, and Blood Institute.
MESA Percentile
LDL particles nmol/L
Interpretation
0–20%
<1,000
Those with lowest rate of cardiovascular disease events & low (optimal) LDL particle concentration
20–50%
1,000–1,299
Those with moderate rate of cardiovascular disease events & moderate LDL particle concentration
50–80%
1,300–1,599
Those with Borderline-High rate of cardiovascular disease events & higher LDL particle concentration
89–95%
1,600–2,000
Those with High rate of cardiovascular disease events and even higher LDL particle concentration
>95%
>2,000
Those with very high rate of cardiovascular disease events and highest LDL particle concentration
The lowest incidence of atherosclerotic events over time occurs within the <20% group, with increased rates for the higher groups. [citation needed] Multiple other measures, including particle sizes, small LDL particle concentrations, large total and HDL particle concentrations, along with estimations of insulin resistance pattern and standard cholesterol lipid measurements (for comparison of the plasma data with the estimation methods discussed above) are also routinely provided.
Lowering LDL-cholesterol
Markers indicating a need for LDL-C Reduction
(Per 2004 United States Government Minimum Guidelines[52][53])
If the patient's cardiac risk is...
then the patient should consider LDL-C reduction if the count in mg/dL is over...
and LDL-C reduction is indicated if the count in mg/dL is over...
High, meaning a 20% or greater risk of heart attack within 10 years, or an extreme risk factor
The mevalonate pathway serves as the basis for the biosynthesis of many molecules, including cholesterol. The enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase) is an essential component and performs the first of 37 steps within the cholesterol production pathway, and is present in every animal cell.[citation needed]
LDL-C is not a measurement of actual LDL particles. LDL-C is only an estimate (not measured from the individual's blood sample) of how much cholesterol is being transported by all LDL particles, which is either a smaller concentration of large particles or a high concentration of small particles. LDL particles carry many fat molecules (typically 3,000 to 6,000 fat molecules per LDL particle); this includes cholesterol, triglycerides, phospholipids and others. Thus even if the hundreds to thousands of cholesterol molecules within an average LDL particle were measured, this does not reflect the other fat molecules or even the number of LDL particles.
Pharmaceutical
PCSK9 inhibitors, in clinical trials, by several companies, are more effective for LDL reduction than the statins, including statins alone at high dose (though not necessarily the combination of statins plus ezetimibe).
Statins reduce high levels of LDL particles by inhibiting the enzyme HMG-CoA reductase in cells, the rate-limiting step of cholesterol synthesis. To compensate for the decreased cholesterol availability, synthesis of LDL receptors (including hepatic) is increased, resulting in an increased clearance of LDL particles from the extracellular water, including of the blood.
Ezetimibe reduces intestinal absorption of cholesterol, thus can reduce LDL particle concentrations when combined with statins.[55]
Niacin (B3), lowers LDL by selectively inhibiting hepatic diacylglycerol acyltransferase 2, reducing triglyceride synthesis and VLDL secretion through a receptor HM74[56] and HM74A or GPR109A.[57]
Several CETP inhibitors have been researched to improve HDL concentrations, but so far, despite dramatically increasing HDL-C, have not had a consistent track record in reducing atherosclerosis disease events. Some have increased mortality rates compared with placebo.
Clofibrate is effective at lowering cholesterol levels, but has been associated with significantly increased cancer and stroke mortality, despite lowered cholesterol levels.[58] Other developed and tested fibrates, e.g. fenofibric acid[59] have had a better track record and are primarily promoted for lowering VLDL particles (triglycerides), not LDL particles, yet can help some in combination with other strategies.
Some tocotrienols, especially delta- and gamma-tocotrienols, are being promoted as statin alternative non-prescription agents to treat high cholesterol, having been shown in vitro to have an effect. In particular, gamma-tocotrienol appears to be another HMG-CoA reductase inhibitor, and can reduce cholesterol production.[60] As with statins, this decrease in intra-hepatic (liver) LDL levels may induce hepatic LDL receptor up-regulation, also decreasing plasma LDL levels. As always, a key issue is how benefits and complications of such agents compare with statins—molecular tools that have been analyzed in large numbers of human research and clinical trials since the mid-1970s.
Phytosterols are widely recognized as having a proven LDL cholesterol lowering efficacy'[61] A 2018 review found a dose-response relationship for phytosterols, with intakes of 1.5 to 3 g/day lowering LDL-C by 7.5% to 12%,[62] but reviews as of 2017 had found no data indicating that the consumption of phytosterols may reduce the risk of CVD.[63] Current supplemental guidelines for reducing LDL recommend doses of phytosterols in the 1.6-3.0 grams per day range (Health Canada, EFSA, ATP III, FDA) with a 2009 meta-analysis demonstrating an 8.8% reduction in LDL-cholesterol at a mean dose of 2.15 gram per day.[64]
Lifestyle
LDL cholesterol can be lowered through dietary intervention by limiting foods with saturated fat and avoiding foods with trans fat.[65] Saturated fats are found in meat products (including poultry), full-fat dairy, eggs, and refined tropical oils like coconut and palm.[66] Added trans fat (in the form of partially hydrogenated oils) has been banned in the US since 2021.[67] However, trans fat can still be found in red meat and dairy products as it is produced in small amounts by ruminants such as sheep and cows.[68] LDL cholesterol can also be lowered by increasing consumption of soluble fiber and plant-based foods.[69]
Another lifestyle approach to reduce LDL cholesterol has been minimizing total body fat, in particular fat stored inside the abdominal cavity (visceral body fat). Visceral fat, which is more metabolically active than subcutaneous fat, has been found to produce many enzymatic signals, e.g. resistin, which increase insulin resistance and circulating VLDL particle concentrations, thus both increasing LDL particle concentrations and accelerating the development of diabetes mellitus.
^Dashty M, Motazacker MM, Levels J, de Vries M, Mahmoudi M, Peppelenbosch MP, Rezaee F (2014). "Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism". Thromb. Haemost. 111 (3): 518–530. doi:10.1160/TH13-02-0178. PMID24500811. S2CID20566238.
^Superko HR, Nejedly M, Garrett B (2002). "Small LDL and its clinical importance as a new CAD risk factor: a female case study". Progress in Cardiovascular Nursing. 17 (4): 167–73. doi:10.1111/j.0889-7204.2002.01453.x. PMID12417832.
^ abStocker, Roland; Keaney, John F. (2004). "Role of Oxidative Modifications in Atherosclerosis". Physiological Reviews. 84 (4): 1381–1478. doi:10.1152/physrev.00047.2003. PMID15383655.
^John D. Brunzell, MD, FACP, Michael Davidson, MD, FACC, Curt D. Furberg, MD, PhD, Ronald B. Goldberg, MD, Barbara V. Howard, PhD, James H. Stein, MD, FACC, FACP and Joseph L. Witztum, MD Lipoprotein Management in Patients With Cardiometabolic Risk, J Am Coll Cardiol, 2008; 51:1512-1524. [1]Archived 2012-02-27 at the Wayback Machine
^Howard, B. V.; Robbins, D. C.; Sievers, M. L.; Lee, E. T.; Rhoades, D.; Devereux, R. B.; Cowan, L. D.; Gray, R. S.; Welty, T. K.; Go, O. T.; Howard, W. J. (2000-03-01). "LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study". Arteriosclerosis, Thrombosis, and Vascular Biology. 20 (3): 830–835. doi:10.1161/01.atv.20.3.830. ISSN1079-5642. PMID10712410.
^Brunzell, John D.; Davidson, Michael; Furberg, Curt D.; Goldberg, Ronald B.; Howard, Barbara V.; Stein, James H.; Witztum, Joseph L. (15 April 2008). "Lipoprotein Management in Patients With Cardiometabolic Risk". J Am Coll Cardiol. 51 (15): 1512–1524. doi:10.1016/j.jacc.2008.02.034. PMID18402913.
^Soudijn W, van Wijngaarden I, Ijzerman AP (May 2007). "Nicotinic acid receptor subtypes and their ligands". Medicinal Research Reviews. 27 (3): 417–33. doi:10.1002/med.20102. PMID17238156. S2CID20876888.
^"WHO cooperative trial on primary prevention of ischemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators". Lancet. 2 (8403): 600–4. September 1984. doi:10.1016/s0140-6736(84)90595-6. PMID6147641. S2CID2473318.
O'Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R (June 2004). "Optimal low-density lipoprotein is 50 to 70 mg/dL: lower is better and physiologically normal". Journal of the American College of Cardiology. 43 (11): 2142–6. doi:10.1016/j.jacc.2004.03.046. PMID15172426.
Early statement of Christian belief Medieval Credo Apostolorum, dated c. 1300 (Bibliothèque Mazarine ms. 0924 f. 150v). The sequence of attribution to the apostles is: 1. Peter, 2. Andrew, 3. John, 4. James, son of Zebedee, 5. Thomas, 6. James, son of Alphaeus, 7. Philip, 8. Bartholomew, 9. Matthew, 10. Simon the Zealot, 11. Jude Thaddaeus, 12. Matthias. Part of a series onChristianity JesusChrist Nativity Baptism Ministry Crucifixion Resurrection Ascension BibleFoundations Old Testame...
كوفيان Kofi-kurd.jpg اللقب كوفي تقسيم إداري البلد سوريا المحافظة محافظة حلب المسؤولون المنطقة منطقة عين العرب الناحية ناحية صرين رمز التجمّع C2104 خصائص جغرافية إحداثيات 36°42′44″N 38°23′07″E / 36.71224°N 38.38535°E / 36.71224; 38.38535 السكان التعداد السكاني 345 نسمة (إحصاء 2022) معلومات أخ
هذه المقالة يتيمة إذ تصل إليها مقالات أخرى قليلة جدًا. فضلًا، ساعد بإضافة وصلة إليها في مقالات متعلقة بها. (أبريل 2019) تشاد كيلي معلومات شخصية الميلاد 26 مارس 1994 (29 سنة) بوفالو، نيويورك مواطنة الولايات المتحدة الطول 74 بوصة الوزن 209 رطل أقرباء جيم كيلي (عم) ...
Species of mammoth Pygmy mammothTemporal range: Late Pleistocene to Early Holocene, 0.06–0.011 Ma PreꞒ Ꞓ O S D C P T J K Pg N ↓ Skeleton at the Santa Barbara Museum of Natural History Model of a pygmy mammoth (front) at the Cleveland Museum of Natural History Scientific classification Domain: Eukaryota Kingdom: Animalia Phylum: Chordata Class: Mammalia Order: Proboscidea Family: Elephantidae Genus: †Mammuthus Species: †M. exilis Binomial name †Mammuthus exi...
Indian television show Ek Ladki Anjaani SiEk Ladki Anjaani SiGenreDramaWritten bySuttapa Sikdar, Rajita, sanjay kumarDirected byRavi Raj, Arvind GuptaStarringKanchi KaulArzoo GovitrikarKarishma TannaCountry of originIndiaNo. of episodes364ProductionProducersMeesha Gautam, Sheel KumarRunning time23 minutesOriginal releaseNetworkSony Entertainment TelevisionRelease21 November 2005 (2005-11-21) –12 February 2007 (2007-02-12) Ek Ladki Anjaani Si is an Indian television series whi...
Julia Ebner (2023) Julia Ebner (* 24. Juli 1991 in Wien) ist eine österreichische Investigativ-Journalistin, Autorin und Politikberaterin. Inhaltsverzeichnis 1 Leben 2 Rezensionen 3 Auszeichnungen 4 Publikationen 5 Weblinks 6 Einzelnachweise Leben Ebner begann 2009 ein Studium im Fach Internationales Management an der Wirtschaftsuniversität Wien, das sie 2013 mit einem B.Sc. abschloss. Parallel begann sie 2010 ein Philosophie-Studium an der Universität Wien, das sie 2013 mit einem B.A. abs...
American prisoner-run magazine in Louisiana The AngoliteFormer editorsWilbert Rideau (original co editor 1975-1987, associate editor 1997-2005)FrequencyBimonthlyFounded1976; 47 years ago (1976)CompanyLouisiana State PenitentiaryCountryUnited StatesBased inAngola, LouisianaLanguageEnglishISSN0402-4249 The Angolite is published from the Louisiana State Penitentiary The Angolite is the inmate-edited and published magazine of the Louisiana State Penitentiary (Angola) in West Fel...
2005 single by Wisin & YandelRakataSingle by Wisin & Yandelfrom the album Mas Flow 2 and Pa'l Mundo ReleasedJanuary 27, 2005[1]Recorded2005GenreReggaetonLength2:52LabelMacheteSongwriter(s) Josias de la Cruz Juan Luis Morera Llandel Veguilla Producer(s) Luny Tunes Nely Wisin & Yandel singles chronology No Me Dejes Solo (2005) Rakata (2005) Mírala Bien (2005) Rakata is the debut single by Puerto Rican reggaeton duo Wisin & Yandel, released on January 27, 2005, by Machet...
عبد الله بن شايق معلومات شخصية الميلاد 3 أكتوبر 1960 قرب المزاحمية، السعودية الوفاة 19 أبريل 2014 (53 سنة) مدينة ظلم سبب الوفاة حادث مرور الجنسية السعودية الأولاد شايق الحياة العملية النوع نبطي المهنة شاعر محاورة - شاعر نظم اللغات العربية سنوات النشاط 1985 - 2014 بوابة الأدب...
Bandera oficial de Escocia. Mapa de Escocia (en azul oscuro) dentro de Reino Unido (en azul claro) junto a la República de Irlanda (en blanco). La cultura escocesa se refiere a las características culturales idiosincráticas propias de Escocia y los escoceses. La cultura de Escocia es una síntesis de las diferentes culturas celtas, pictas e inglesas, principalmente, que han bañado el país. Los relieves naturales, que delimitan geográficamente las tierras altas (Highlands), montañosas y...
Football match1950 FA Charity ShieldThe match programme coverEventFA Charity Shield England World Cup XI F.A. Canadian Touring Team 4 2 Date20 September 1950VenueStamford Bridge, LondonRefereeArthur EllisAttendance38,468← 1949 1951 → The 1950 FA Charity Shield was the 28th FA Charity Shield, an early season exhibition football match hosted by The Football Association. The 1950 match was held between the England squad that had competed at the 1950 World Cup, and the squad that had ...
Human settlement in EnglandUpper DenfordUpper DenfordLocation within BerkshireOS grid referenceSU355695Metropolitan boroughWest BerkshireMetropolitan countyBerkshireRegionSouth EastCountryEnglandSovereign stateUnited KingdomPost townHUNGERFORDPostcode districtRG17Dialling code01488PoliceThames ValleyFireRoyal BerkshireAmbulanceSouth Central UK ParliamentBerkshire List of places UK England Berkshire 51°25′28″N 1°29′02″W / 51.424...
Nahdlatul WathanSingkatanNWPendahuluNU Sunda KecilTanggal pendirian1 Maret 1953PendiriT.G.K.H. Muhammad Zainuddin Abdul MadjidDidirikan diPancor, Lombok TimurStatusAktifTipeOrganisasiTujuanPendidikan, dakwah, dan sosialKetua UmumRTGB. Lalu Gede Muhammad Zainuddin AtsaniSitus webnw.or.id Nahdlatul Wathan (Arab: نهضة الوطن Nahḍah al-Waṭan, terj. har. 'Kebangkitan Bangsa'), disingkat NW, adalah organisasi massa Islam dari Nusa Tenggara Barat. Organisasi ini didirikan pada ...
De zaak Natalee HollowayThe Case of Natalee Holloway AuthorJoran van der SlootZvezdana VukojevicCountryNetherlandsLanguageDutchGenreAutobiography, true crimePublisherSijthoffPublication dateApril 1, 2007[1]Pages350ISBN978-90-218-0014-1OCLC150235828 De zaak Natalee Holloway: mijn eigen verhaal over haar verdwijning op Aruba (English: The Case of Natalee Holloway: My own story about her disappearance in Aruba) is an autobiographical non-fiction book written by Joran van der Sloot with Z...
Chapman James ClareChapman James Clare from The Adelaide Chronicle, 5 July 1902Born(1853-06-23)23 June 1853Bay of BiscayDied28 September 1940(1940-09-28) (aged 87)Glenelg, Adelaide, AustraliaNationalityBritish, AustralianOccupationSailorKnown forCoastwatchers Chapman James Clare CMG (23 June 1853 – 28 September 1940) was a British sailor who worked on merchant vessels, then on Australian government ships, and after formation of the Royal Australian Navy as a senior naval officer. ...
Army Black Knights 2023 Army Black Knights baseball teamFounded1890 (1890)UniversityUnited States Military AcademyHead coachChris Tracz (1st season)ConferencePatriot LeagueLocationWest Point, New YorkHome stadiumJohnson Stadium at Doubleday Field (Capacity: 880)NicknameBlack KnightsColorsBlack, gold, and gray[1] NCAA Tournament appearances2000, 2004, 2005, 2009, 2012, 2013, 2018, 2019, 2021, 2022, 2023Conference tournament champions1997...
2000 single by Silkk the Shocker This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: He Did That – news · newspapers · books · scholar · JSTOR (July 2011) (Learn how and when to remove this template message) He Did ThatSingle by Silkk the Shocker featuring Mac and Master Pfrom the album My World, My Way ReleasedSeptember 5, 2000R...
Koninklijke Nederlandse Akademie van Wetenschappen Die Koninklijke Nederlandse Akademie van Wetenschappen (KNAW) is 'n vereniging van uitmuntende skolastici. Die organisasie bestaan uit nasionale wetenskaplike institute en 'n adviesliggaam vir die Nederlandse regering op die gebied van die wetenskappe. Die Akademie is geleë in die Trippenhuis in Amsterdam. Doel en take van die Akademie Die doel van die Akademie is om die beoefening van die wetenskappe in Nederland te bevorder. Die meeste an...
Stargate OriginsGen Acțiune-Aventură Science fiction Creator(i)Mark IlvedsonJustin Michael TerryBazat peStargateby Roland EmmerichDean DevlinActori Ellie Gall Connor Trinneer Aylam Orian Philip Alexander Shvan Aladdin Țară de origineStatele UniteLimbă(i)englezăNr. de sezoane1Nr. de episoade10ProducțieProducător(i) executiv(i)Mercedes Bryce MorganPerioadă de difuzare10 minuteCompanie(i) de producție United Artists New Form DifuzareCanal originalStargate CommandDifuzare originală14 f...
Large 18th-century Palladian country house in Norfolk, England Holkham Hall. The severely Palladian south facade with its Ionic portico is devoid of arms or motif; not even a blind window is allowed to break the void between the windows and roof-line, while the lower windows are mere piercings in the stark brickwork. The only hint of ornamentation is from the two terminating Venetian windows. Holkham Hall (/ˈhoʊkəm/ or /ˈhɒlkəm/[1]) is an 18th-century country house near the vill...